Anti-TNFα drugs linked to HBV reactivation

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1522, 2006-01, pp. : 17-17

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Lamivudine may prevent HBV reactivation

Inpharma, Vol. 1, Iss. 1397, 2003-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Compliance with NICE guidance on the use of anti-TNFα agents in ankylosing spondylitis: an East and West Midlands regional audit

By Rees Frances Peffers Gillian Bell Carolyn Obrenovic Karen Sandhu Ravinder Packham Jonathan Erb Nicola

Clinical Medicine, Vol. 12, Iss. 4, 2012-08 ,pp. : 324-327

Royal College Of Physicians

Access to resources Recommend Favorite

Antiviral Drugs in the Prophylaxis of HBV Infection

Current Medicinal Chemistry, Vol. 19, Iss. 35, 2012-12 ,pp. : 5940-5946

Bentham Science Publishers

Access to resources Recommend Favorite

Nucleoside Analogs as Anti-HBV Agents

Current Topics in Medicinal Chemistry, Vol. 6, Iss. 9, 2006-05 ,pp. : 851-865

Bentham Science Publishers

Access to resources Recommend Favorite

Antineoplastics/antivirals: HBV reactivation after chemotherapy and fatal lactic acidosis associated with antivirals?: case report

Reactions Weekly, Vol. 1, Iss. 1292, 2010-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite